IP Library › Granted Patent US 12,326,446
Granted Patent B2
US 12,326,446 · App. 17/713,181 · Granted Jun 10, 2025

Sequential lateral flow device

Inventors: Gregory M. Lawrence (Marlborough, MA); Adam P. Lousararian (Marlborough, MA); Yli Remo Vallejo (Marlborough, MA); Lisa Shinefeld (Marlborough, MA)
Assignee: Verax Biomedical Incorporated
G01N33/54388B01L3/5023B01L3/502715G01N33/5304G01N33/566G01N33/56911G01N33/577B01L2300/069B01L2300/0825B01L2400/0406
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,326,446
App. No.
17/713,181
Granted
Jun 10, 2025
Kind
B2
Abstract

The present disclosure provides methods and lateral flow devices for detecting a plurality of target analytes in a liquid sample. In some implementations, the disclosed lateral flow device comprises a housing unit, a capillary flow bed, a sample-receiving zone, a buffer-receiving zone, and a capture zone. The device is configured to control the flow of the sample and reagent buffer in a sequential manner with minimal mixing. In some implementations, the disclosed method is capable of detecting a plurality of target analytes in an assay by applying the binding agents and the signaling agents in separate or sequential steps.

Claims (28)

1. A lateral flow device for detecting a plurality of target analytes in a liquid sample, the device comprising:

a housing unit comprising an inner surface that defines a cavity in the housing unit;

a capillary flow bed residing in the cavity, wherein the capillary flow bed transports the liquid sample from a proximal region of the capillary flow bed to a distal region of the capillary flow bed;

a buffer-receiving zone comprising a buffer-receiving pad (P B ) and a conjugate pad (P C ), the conjugate pad comprising a signaling agent for providing a detectable signal;

a capture zone (C) comprising a plurality of immobilized capture agents;

a sample-receiving zone disposed between the buffer-receiving zone and the capture zone, the sample-receiving zone comprising a sample-receiving pad (P S ), a transfer pad (P T ), and a substantially impermeable backing disposed between the sample-receiving zone and the capillary flow bed and extending at least partially underneath the sample-receiving pad and the transfer pad, the transfer pad comprising a plurality of binding agents that specifically bind to a plurality target analytes;

a bibulous reservoir pad (R) disposed in the distal region of the capillary flow bed;

a first inlet (I 1 ) in said housing for introducing the liquid sample into the sample-receiving pad, wherein the impermeable backing inhibits contact between the liquid sample and the capillary flow bed in the sample-receiving zone, thereby reducing backflow of the sample in a proximal direction;

a second inlet (I 2 ) in said housing for introducing a buffer into the buffer-receiving pad, wherein the buffer mobilizes the signaling agent to obtain a mobilized signaling agent; and

a reading window defined in the housing unit over the capture zone for observing a detectable signal produced by an interaction of the binding agent and the signaling agent in the presence of the target analyte;

wherein the bibulous reservoir pad draws the liquid sample and the mobilized signaling agent in the distal flow direction, and wherein the liquid sample flows along the capillary flow bed into the capture zone before the mobilized signaling agent flows into the capture zone.

2. The lateral flow device of claim 1 , wherein the inner surface of the housing unit comprises a series of ribs which retain excess fluid, thereby inhibiting the excess fluid from overflowing the sample-receiving pad or the buffer-receiving pad.

3. The lateral flow device of claim 2 , wherein the series of ribs are disposed over the sample-receiving pad on the upper inner surface of the housing unit.

4. The lateral flow device of claim 2 , wherein the series of ribs are disposed over the buffer-receiving pad on the upper inner surface of the housing unit.

5. The lateral flow device of claim 1 , wherein the inner surface of the housing unit comprises at least one pinch point pressing the buffer-receiving pad into the conjugate pad to create a flow path for the buffer to flow from the buffer-receiving pad to the conjugate-pad.

6. The lateral flow device of claim 1 , wherein the inner surface of the housing unit comprises at least one pinch point pressing the sample-receiving pad into the transfer pad to create a flow path for the liquid sample to flow from the sample-receiving pad to the transfer-pad.

7. The lateral flow device of claim 1 , wherein the inner surface of the housing unit comprises at least one pinch point pressing the transfer pad into a flow path bed to create a flow path for the liquid sample from the transfer-pad to the capillary flow bed.

8. The lateral flow device of claim 1 , wherein the capillary flow bed is slightly bent to promote capillary action and minimize flooding.

9. The lateral flow device of claim 1 , wherein the plurality of capture agents in the capture zone comprise one or more types of capture agents each adapted to a common antigen of at least a subset of target analytes in the liquid sample.

10. The lateral flow device of claim 1 , wherein the plurality of the capture agents bind a Gram-positive and/or Gram-negative bacterial antigen.

11. The lateral flow device of claim 1 , wherein the plurality of the capture agents comprise antibodies.

12. The lateral flow device of claim 1 , wherein the plurality of capture agents comprise one or more capture agent groupings on the capillary flow bed, the groupings spatially separated from each other, each grouping comprising an antibody that binds to a different target or analyte.

13. The lateral flow device of claim 1 , wherein the plurality of binding agents bind a Gram-positive and/or Gram-negative bacterial antigen.

14. The lateral flow device of claim 1 , wherein the plurality of binding agents comprise antibodies.

15. The lateral flow device of claim 1 , wherein each of the plurality of binding agents is labeled with a first member of a conjugate pair and the signaling agent is labeled with a second member of the conjugate pair.

16. The lateral flow device of claim 15 , wherein the conjugate pair comprises biotin and a biotin-binding protein, and either the binding agent or the signaling agent is labeled with biotin.

17. The lateral flow device of claim 1 , wherein the capillary flow bed comprises nitrocellulose.

18. The lateral flow device of claim 1 , wherein the sample-receiving pad, the buffer-receiving pad, the bibulous reservoir pad, and the conjugate pad each comprises a bibulous material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2022
From: LAWRENCE, GREGORY M.; VALLEJO, YLI REMO; LOUSARARIAN, ADAM P.; SHINEFELD, LISA
To: VERAX BIOMEDICAL INCORPORATED
Reel/Frame 059605/0739 →
Continuity (3)
Division 16047980 · Jul 27, 2018
Provisional Application 62537701 · Jul 27, 2017
Related Publication 20220236265A1 · Jul 28, 2022
References Cited (35)
US 4981786A · Dafforn · 1991 [cited by examiner]
US 5384264A · Chen · 1995 [cited by examiner]
US 5773234A · Pronovost · 1998 [cited by applicant]
US 6790661B1 · Goodnow · 2004 [cited by applicant]
US 7371582B2 · Nahm et al. · 2008 [cited by applicant]
US 7871781B2 · Rundstrom · 2011 [cited by examiner]
US 8003407B2 · Zhou · 2011 [cited by applicant]
US 8222046B2 · Xia · 2012 [cited by examiner]
US 11293922B2 · Vallejo et al. · 2022 [cited by applicant]
US 20080138842A1 · Boehringer et al. · 2008 [cited by applicant]
US 20100221747A1 · Ito · 2010 [cited by applicant]
US 20110129815A1 · Yamagaito et al. · 2011 [cited by applicant]
US 20110136258A1 · Sambursky et al. · 2011 [cited by applicant]
US 20130164193A1 · Semenov · 2013 [cited by examiner]
US 20130217147A1 · Gibbons et al. · 2013 [cited by applicant]
US 20130309656A1 · Davis · 2013 [cited by applicant]
US 20150251177A1 · Kim · 2015 [cited by applicant]
US 20160011185A1 · Lawrence · 2016 [cited by applicant]
US 20190004042A1 · Erickson · 2019 [cited by examiner]
EP 1044372A1 · 2000 [cited by applicant]
JP 2003517586A · 2003 [cited by applicant]
JP 2011179865A · 2011 [cited by applicant]
WO WO90008322A1 · 1990 [cited by applicant]
WO WO2000025135A1 · 2000 [cited by applicant]
WO WO2001006258A1 · 2001 [cited by applicant]
WO WO2002044729A1 · 2002 [cited by applicant]
WO WO2007069673A1 · 2007 [cited by applicant]
WO WO2008073222A2 · 2008 [cited by examiner]
WO WO2014055995A1 · 2014 [cited by applicant]
WO WO2019023597A1 · 2019 [cited by applicant]
Laverda, D. et al., “Improved Detection of Gram-Negative Platelet Isolates With Next-Generation Platelet PGD Test,” the AABB Annual Meeting, Oct. 2015, [online], [retrieved on Sep. 27, 2022], Internet <URL:https://www.v… [cited by applicant]
Fridley, Gina E., Huy Le, and Paul Yager. “Highly sensitive immunoassay based on controlled rehydration of patterned reagents in a 2-dimensional paper network.” Acatytical chemistry 86.13 (2014): 6447-6453. [cited by applicant]
Fu, Elain, ei al. “Controlled reagent transport in disposable 2D paper networks. Lab on a Chip,” Royal Society of Chemistry, 10.7 (2010): 918-920. [cited by applicant]
Teiwes, Hanno. “A Paper-Based Lateral Flow Device for the Detection of I.alpha.IA Via Elisa”. (2014). [cited by applicant]
International Search Report in International Application No. PCT/US18/44123 dated Nov. 28, 2018. [cited by applicant]